AAAAAA
Results:
1-23
|
Results: 23
Authors:
Castellano, PZ
Wenger, NK
Graves, WL
Citation: Pz. Castellano et al., Adherence to screening guidelines for breast and cervical cancer in postmenopausal women with coronary heart disease: An ancillary study of volunteers for HERS, J WOMEN H G, 10(5), 2001, pp. 451-461
Authors:
Wenger, NK
Citation: Nk. Wenger, A cardiologist's view of hormone replacement therapy and alternatives for cardioprotection, J WOMEN H G, 10(3), 2001, pp. 257-260
Authors:
Wenger, NK
Citation: Nk. Wenger, Managing ambulatory anticoagulation, J THROMB TH, 12(1), 2001, pp. 31-34
Authors:
Shlipak, MG
Simon, JA
Grady, D
Lin, F
Wenger, NK
Furberg, CD
Citation: Mg. Shlipak et al., Renal insufficiency and cardiovascular events in postmenopausal women withcoronary heart disease, J AM COL C, 38(3), 2001, pp. 705-711
Authors:
Dilley, A
Hooper, WC
El-Jamil, M
Renshaw, M
Wenger, NK
Evatt, BL
Citation: A. Dilley et al., Mutations in the genes regulating methylene tetrahydrofolate reductase (MTHFR C -> T677) and cystathione beta-synthase (CBS G -> A919, CBS T -> c833)are not associated with myocardial infarction in African Americans, THROMB RES, 103(2), 2001, pp. 109-115
Authors:
Mosca, L
Collins, P
Herrington, DM
Mendelsohn, ME
Pasternak, RC
Robertson, RM
Schenck-Gustafsson, K
Smith, SC
Taubert, KA
Wenger, NK
Citation: L. Mosca et al., Hormone replacement therapy and cardiovascular disease - A statement for healthcare professionals from the American Heart Association, CIRCULATION, 104(4), 2001, pp. 499-503
Authors:
Mosca, L
Barrett-Connor, E
Wenger, NK
Collins, P
Grady, D
Kornitzer, M
Moscarelli, E
Paul, S
Wright, TJ
Helterbrand, JD
Anderson, PW
Citation: L. Mosca et al., Design and methods of the raloxifene use for the heart (RUTH) study, AM J CARD, 88(4), 2001, pp. 392-395
Authors:
Wenger, NK
Citation: Nk. Wenger, Lipid management and control of other coronary risk factors in the postmenopausal woman, J WOMEN H G, 9(3), 2000, pp. 235-243
Authors:
Austin, H
Hooper, WC
Lally, C
Dilley, A
Ellingsen, D
Wideman, C
Wenger, NK
Rawlins, P
Silva, V
Evatt, B
Citation: H. Austin et al., Venous thrombosis in relation to fibrinogen and factor VII genes among African-Americans, J CLIN EPID, 53(10), 2000, pp. 997-1001
Authors:
Wenger, NK
Knatterud, GL
Canner, PL
Citation: Nk. Wenger et al., Early risks of hormone therapy in patients with coronary heart disease, J AM MED A, 284(1), 2000, pp. 41-43
Authors:
Hooper, WC
Lally, C
Austin, H
Renshaw, M
Dilley, A
Wenger, NK
Phillips, DJ
Whitsett, C
Rawlins, P
Evatt, BL
Citation: Wc. Hooper et al., The role of the t-PA I/D and PAI-1 4G/5G polymorphisms in African-Americanadults with a diagnosis of myocardial infarction or venous thromboembolism, THROMB RES, 99(3), 2000, pp. 223-230
Authors:
Grady, D
Wenger, NK
Herrington, D
Khan, S
Furberg, C
Hunninghake, D
Vittinghoff, E
Hulley, S
Citation: D. Grady et al., Postmenopausal hormone therapy increases risk for venous thromboembolic disease - The heart and estrogen/progestin replacement study, ANN INT MED, 132(9), 2000, pp. 689
Authors:
Wenger, NK
Citation: Nk. Wenger, Should women have a different risk assessment from men for primary prevention of coronary heart disease?, J WOMEN H G, 8(4), 1999, pp. 465-467
Authors:
Wenger, NK
Grady, D
Citation: Nk. Wenger et D. Grady, Postmenopausal hormone therapy, SERMs, and coronary heart disease in women, J ENDOC INV, 22(8), 1999, pp. 616-624
Authors:
Wenger, NK
Citation: Nk. Wenger, Postmenopausal hormone use for cardioprotection: What we know and what we must learn, CURR OPIN C, 14(4), 1999, pp. 292-297
Authors:
Hooper, WC
Lally, C
Austin, H
Benson, J
Dilley, A
Wenger, NK
Whitsett, C
Rawlins, P
Evatt, BL
Citation: Wc. Hooper et al., The relationship between polymorphisms in the endothelial cell nitric oxide synthase gene and the platelet GPIIIa gene with myocardial infarction andvenous thromboembolism in African Americans, CHEST, 116(4), 1999, pp. 880-886
Authors:
Wenger, NK
Citation: Nk. Wenger, Diagnostic testing for coronary heart disease in women: New information generates new questions, AM HEART J, 137(6), 1999, pp. 983-984
Authors:
Wenger, NK
Citation: Nk. Wenger, The natural history of coronary artery disease in women - Epidemiology, coronary risk factors, and clinical characteristics, WOMENS HLTH, 1999, pp. 3-35
Authors:
Wenger, NK
Citation: Nk. Wenger, Overview: Charting the course for cardiac rehabilitation into the 21st century, FUND CL CAR, 38, 1999, pp. 1-7
Authors:
Smith, LK
Wenger, NK
Citation: Lk. Smith et Nk. Wenger, Benefits of exercise training, FUND CL CAR, 38, 1999, pp. 9-18
Authors:
Wenger, NK
Smith, LK
Froelicher, ES
Comoss, PM
Citation: Nk. Wenger et al., Challenges and opportunities for additional research, FUND CL CAR, 38, 1999, pp. 467-470
Authors:
Barrett-Connor, E
Wenger, NK
Grady, D
Mosca, L
Collins, P
Kornitzer, M
Cox, DA
Moscarelli, E
Anderson, PW
Citation: E. Barrett-connor et al., Coronary heart disease in women: Randomized clinical trials, HERS and RUTH, MATURITAS, 31(1), 1998, pp. 1-7
Authors:
Dilley, A
Austin, H
Hooper, WC
El-Jamil, M
Whitsett, C
Wenger, NK
Benson, J
Evatt, B
Citation: A. Dilley et al., Prevalence of the prothrombin 20210 G-to-A variant in blacks: Infants, patients with venous thrombosis, patients with myocardial infarction, and control subjects, J LA CL MED, 132(6), 1998, pp. 452-455
Risultati:
1-23
|